Publication | Closed Access
Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancer
35
Citations
22
References
2013
Year
Loss of SATB1 nuclear expression correlates with poor survival and a less favourable response to adjuvant chemotherapy in colorectal cancer. The value of SATB1 in individualized colorectal cancer therapy warrants further evaluation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1